Document Detail


Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome.
MedLine Citation:
PMID:  14513399     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We describe the successful treatment of pyoderma gangrenosum (PG) that developed in a patient with myelodysplastic syndrome (MDS). A 63-year-old Japanese man with MDS was admitted to our hospital because of a large skin ulcer on his neck in November 2001. The initial diagnosis was infectious dermatitis, and antimicrobial therapy was performed, using imipenem/cilastatin, isepamicin, and amphotericin B. However, this therapy was not effective, and the lesion worsened. Cultures of blood, throat swab, and ulcer pus yielded no microorganisms. A biopsy of the skin lesion revealed a severe infiltration of neutrophils in the dermis, without any evidence of infection. The lesion was finally diagnosed as PG, and systemic administration of corticosteroid hormone was started in December 2001. The patient was initially pulsed with 1 g methylprednisolone daily for 3 days. The dose was immediately reduced, and the treatment was maintained with 30 mg prednisolone daily. The skin lesion responded markedly to the therapy, and C-reactive protein became negative. The patient was discharged in February 2002 because the lesion was almost cured. Prednisolone administration was tapered after 6-month maintenance therapy. No recurrence of PG was seen, although his MDS transformed into leukemia in April 2003. Only 31 cases of MDS developing PG have been reported in the past 20 years in Japan. This report describes one such rare patient who was successfully treated with the use of high-dose pulse methylprednisolone and long-term maintenance therapy.
Authors:
Takahiro Yamauchi; Kentaro Ishida; Yoshiko Iwashima; Satoshi Ikegaya; Yasukazu Kawai; Mami Wakahara; Masanobu Kumakiri; Takanori Ueda
Related Documents :
10886269 - Long-term evaluation of the long-pulsed alexandrite laser for the removal of bikini hai...
18613879 - Granular parakeratosis.
20484539 - Skin collagen synthesis is depressed in patients with severe sepsis.
16026699 - C reactive protein and skin temperature post total knee replacement.
20442099 - Safety and efficacy of ultrashape contour i treatments to improve the appearance of bod...
932489 - Percutaneous absorption after twenty-five years: or "old wine in new wineskins".
14762749 - Stability of skeletal class iii malocclusion after combined maxillary and mandibular pr...
10496589 - Snapping popliteus tendon syndrome. a cause of mechanical knee popping in athletes.
15486889 - The treatment of high and intermediate anorectal malformations: one stage or three proc...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy     Volume:  9     ISSN:  1341-321X     ISO Abbreviation:  J. Infect. Chemother.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-09-26     Completed Date:  2003-12-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9608375     Medline TA:  J Infect Chemother     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  268-71     Citation Subset:  IM    
Affiliation:
First Department of Internal Medicine, Fukui Medical University, 23, Shimoaizuki, Matsuoka, Fukui 910-1193, Japan. tyamauch@fmsrsa.fukui-med.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Diagnosis, Differential
Humans
Male
Methylprednisolone / administration & dosage
Middle Aged
Myelodysplastic Syndromes*
Neck
Pyoderma Gangrenosum / diagnosis*,  drug therapy,  pathology
Skin Ulcer / diagnosis,  drug therapy,  pathology
Chemical
Reg. No./Substance:
83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  CMV infection and pneumonia in hematological malignancies.
Next Document:  Clinical analysis of recent lower lung field tuberculosis.